Style | Citing Format |
---|---|
MLA | Shafiee F, Yazdani A. "Recombinant Production of Interleukin-1 Receptor Antagonist in Fusion to Albumin Binding Domain With Potential Affinity to Human Serum Albumin." Research in Pharmaceutical Sciences, vol. 19, no. 3, 2024, pp. 356-365. |
APA | Shafiee F, Yazdani A (2024). Recombinant Production of Interleukin-1 Receptor Antagonist in Fusion to Albumin Binding Domain With Potential Affinity to Human Serum Albumin. Research in Pharmaceutical Sciences, 19(3), 356-365. |
Chicago | Shafiee F, Yazdani A. "Recombinant Production of Interleukin-1 Receptor Antagonist in Fusion to Albumin Binding Domain With Potential Affinity to Human Serum Albumin." Research in Pharmaceutical Sciences 19, no. 3 (2024): 356-365. |
Harvard | Shafiee F, Yazdani A (2024) 'Recombinant Production of Interleukin-1 Receptor Antagonist in Fusion to Albumin Binding Domain With Potential Affinity to Human Serum Albumin', Research in Pharmaceutical Sciences, 19(3), pp. 356-365. |
Vancouver | Shafiee F, Yazdani A. Recombinant Production of Interleukin-1 Receptor Antagonist in Fusion to Albumin Binding Domain With Potential Affinity to Human Serum Albumin. Research in Pharmaceutical Sciences. 2024;19(3):356-365. |
BibTex | @article{ author = {Shafiee F and Yazdani A}, title = {Recombinant Production of Interleukin-1 Receptor Antagonist in Fusion to Albumin Binding Domain With Potential Affinity to Human Serum Albumin}, journal = {Research in Pharmaceutical Sciences}, volume = {19}, number = {3}, pages = {356-365}, year = {2024} } |
RIS | TY - JOUR AU - Shafiee F AU - Yazdani A TI - Recombinant Production of Interleukin-1 Receptor Antagonist in Fusion to Albumin Binding Domain With Potential Affinity to Human Serum Albumin JO - Research in Pharmaceutical Sciences VL - 19 IS - 3 SP - 356 EP - 365 PY - 2024 ER - |